Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.12 USD | +2.07% | -1.42% | -6.29% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
Financials (USD)
Sales 2024 * | 600M | Sales 2025 * | 625M | Capitalization | 1.49B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | -41M | EV / Sales 2024 * | 2.48 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.39 x |
P/E ratio 2024 * |
108
x | P/E ratio 2025 * |
-36.6
x | Employees | 652 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.98% |
Latest transcript on Supernus Pharmaceuticals, Inc.
1 day | +2.07% | ||
1 week | -1.42% | ||
1 month | -9.84% | ||
3 months | -12.54% | ||
6 months | -1.67% | ||
Current year | -6.29% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 05-03-29 |
Timothy Dec
DFI | Director of Finance/CFO | 65 | 21-08-22 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 63 | 15-03-22 |
Charles Newhall
CHM | Chairman | 78 | 05-03-29 |
John Siebert
BRD | Director/Board Member | 84 | 10-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 28 M€ | -1.00% | ||
0.94% | 14 M€ | -5.07% | ||
0.38% | 25 M€ | -2.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 27.12 | +2.07% | 527,138 |
24-05-30 | 26.57 | -.--% | 554,971 |
24-05-29 | 26.57 | -1.85% | 589,495 |
24-05-28 | 27.07 | -1.60% | 481,941 |
24-05-24 | 27.51 | -0.94% | 453,220 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.29% | 1.49B | |
+15.54% | 78.51B | |
+12.05% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+21.94% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B |
- Stock Market
- Equities
- SUPN Stock